Noven is a fully-integrated specialty pharmaceutical company with industry-leading transdermal expertise

About Noven - Hisamitsu Parent Company

Our Parent Company

Hisamitsu Building

We are a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., the world’s largest manufacturer of transdermal patches. We serve as Hisamitsu's growth platform in U.S. prescription pharmaceuticals. Hisamitsu develops and markets both prescription and over-the-counter ("OTC") pharmaceutical products. Its leading prescription products in Japan are the Mohrus® patch and Mohrus-Tape® ketoprofen pain relief products. Available in nearly 50 countries including the U.S., Hisamitsu's leading OTC products are sold under the Salonpas® brand for pain relief. Hisamitsu was founded in 1847 and is principally located in Saga, Japan.

Noven and Hisamitsu share a common vision of benefiting patients, and to this end work closely and collaboratively across a range of functions including product development, manufacturing, and business development.

For additional information on Hisamitsu, click here.

For additional information on Hisamitsu's Salonpas® brand of products click here.

Fast Facts

Core Business:

Specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products.

Year of Incorporation:



Over 650

President & Chief Executive Officer:

Jeffrey F. Eisenberg

Media, General Business
& Other Inquiries:

Joseph C. Jones
Vice President – Corporate Affairs
Tel: 305-253-1916

Partnering and Other Business Development Opportunities

Tel: 212-287-0988

Physican Payment
Sunshine Act Inquiries:

Employment Inquiries:

Rory Kelly
Corporate Recruiter
Tel: 305-964-3588
Careers Page

Community Support:

Corporate Social Responsibility

Affiliated Companies:

Noven is a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc.


Noven Therapeutics, LLC is Noven's specialty pharmaceuticals marketing and sales company focusing on Women's Health products.